Episode 507: ASCO 2026 - TALAPRO-3

Episode 507: ASCO 2026 - TALAPRO-330 May42 min

Listen on SpotifyAlso works in your browser

Apple PodcastsOpen
YouTubeOpen
Pocket Castsopens the podcast
Amazon Musicopens the podcast
Deezeropens the podcast

5 more apps

Overcastopens the podcast
Player FMopens the podcast
Castroopens the podcast
Podcast Addictopens the podcast
RSSopens the podcast

Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets.